Mostrar el registro sencillo del ítem

dc.contributor.authorLuchi, Adriano Martín
dc.contributor.authorBogado, María Lucrecia
dc.contributor.authorVillafañe, Roxana Noelia
dc.contributor.authorAngelina, Emilio Luis
dc.contributor.authorPeruchena, Nélida María
dc.date.accessioned2025-02-19T18:35:27Z
dc.date.available2025-02-19T18:35:27Z
dc.date.issued2018-12-06
dc.identifier.citationLuchi, Adriano Martín, 2018. Charge density as a molecular descriptor to reveal differences on high active cruzain inhibitors. En: Drug Discovery for Neglected Diseases International Congress 2018. Buenos Aires: Consejo Nacional De Investigaciones Científicas Y Técnicas; Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de la Química y Metabolismo del Fármaco, p. 252-256.es
dc.identifier.isbn978-987-47034-0-8es
dc.identifier.urihttp://repositorio.unne.edu.ar/handle/123456789/56431
dc.description.abstractAvailable chemotherapy for Chagas disease (CD) involves severe side effects and drug- resistance has been observed in some trypanosome strains. Thus, the discovery of new, safer and more effective drugs to treat CD is required [1]. Cruzain (Cz), a cysteine protease of the papain-like family, plays a vital role at every stage of the parasite’s life cycle. The active-site region of enzyme is similar to those of other members of the papain superfamily with seven substrate-binding subsites, four (S4, S3, S2, S1) on the acyl side and three (S1′, S2′, S3′) on the amino side of the cleaved substrate bond [2]. Currently, 25 inputs associated to this molecular target are registered in the Protein Data Bank (rcsb.org), where Cz has been co-crystallized with reversible and irreversible inhibitors. Thereby, Cz presents itself as an interesting target for development of potential therapeutics for the treatment of the disease by employing a structure-based approach. Among Cz inhibitors, those containing a vinyl sulfone warhead can exhibit good selectivity and a favorable in vivo safety profile despite the irreversible nature of inhibition [1]. Jaishankar et al. synthesized and determined the inhibition constant (and binding energies, ΔG) of a series of vinyl sulfone analogs. However, the analysis of key interactions among sub-pockets, that might explain the activity differences between the ligands, is not available yet [3]. The quantum theory of atoms in molecules (QTAIM) provides an important insight into the molecular interactions in ligand-receptor (L-R) complexes [4]. Through the mapping of the gradient vector field onto the complex charge density, a series of topological elements arise. Among these topological elements, the bond critical point (BCP) and, in particular, the charge density value (ρb) at an interaction BCP is considered as a measure of that interaction strength. Unlike ΔG that is a global property of the entire system, ρb is a local property measured at each interaction BCP. This means that ρb can be used to decompose the binding energy in contributions by groups of atoms [5]. Accordingly, the aim of this work was to exploit charge density to decompose total binding energy in contributions by sub-pockets of Cz. In other words, we want to know how strong is the anchoring of known inhibitors to each Cz sub-pocket. This analysis allowed us to identify easily the anchoring points that could be improved (by optimizing inhibitors structure) in order to increase inhibitor affinity to Cz.es
dc.formatapplication/pdfes
dc.format.extentp. 252-256es
dc.language.isoenges
dc.publisherConsejo Nacional De Investigaciones Científicas Y Técnicases
dc.publisherUniversidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de la Química y Metabolismo del Fármacoes
dc.rightsopenAccesses
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/ar/es
dc.subjectChagases
dc.subjectParasite’ses
dc.subjectChemotherapyes
dc.titleCharge density as a molecular descriptor to reveal differences on high active cruzain inhibitorses
dc.typeCongresoes
unne.affiliationFil: Luchi, Adriano Martín. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas y Naturales y Agrimensura; Argentina.es
unne.affiliationFil: Bogado, María Lucrecia. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas y Naturales y Agrimensura; Argentina.es
unne.affiliationFil: Villafañe, Roxana Noelia. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas y Naturales y Agrimensura; Argentina.es
unne.affiliationFil: Angelina, Emilio Luis. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas y Naturales y Agrimensura; Argentina.es
unne.affiliationFil: Peruchena, Nélida María. Universidad Nacional del Nordeste. Facultad de Ciencias Exactas y Naturales y Agrimensura; Argentina.es
unne.event.cityBuenos Aireses
unne.event.countryArgentinaes
unne.event.titleDrug Discovery for Neglected Diseases International Congress 2018es


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

openAccess
Excepto si se señala otra cosa, la licencia del ítem se describe comoopenAccess